8 Articles found

Vicarious Surgical articles

The Top 5 medtech news stories of 2021

The lingering COVID-19 pandemic was top of mind in 2021, but there was much more going on in the medical device industry. The Life Sciences editorial team here at WTWH Media discussed their top picks during the December 17 episode of our DeviceTalks Weekly podcast.

Read Entire Article on Medical Design & Outsourcing

Dec. 28, 2021

Chris

Robotic Surgery: Who will be the Next Top Dog?

The competitive stakes in robotic surgery have never been higher as medical device companies try to disrupt the market that Intuitive Surgical pioneered more than two decades ago.

Robotic surgery pioneer Intuitive Surgical celebrated a big milestone this week: The number of robotic-assisted procedures performed worldwide using the da Vinci surgical sy

Dec. 20, 2021

Amanda Pedersen

Using Consumer Technology to Pilot Miniature Surgical Robots

Read Entire Article on MIT Horizon

Dec. 15, 2021

MIT Horizon

Vicarious Surgical details its regulatory plans with FDA

Vicarious Surgical (NYSE:RBOT) announced in its quarterly earnings report that it set its FDA regulatory process in motion with a pre-submission.

CEO Adam Sachs said in a news release that the robotic surgery technology developer, which just completed its first quarter as a publicly-traded company, filed a “detailed regulatory plan” in the form of a pre-submission to the

Nov. 8, 2021

Sean Whooley

Robotics startup Vicarious files pre-submission with FDA, fresh from $220M SPAC raise

Vicarious Surgical has filed a pre-submission with the FDA, marking the start of a regulatory process it hopes will lead to a 510(k) application by late 2023.

Dive Brief:

Vicarious Surgical

Nov. 8, 2021

Nick Paul Taylor